Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT04807803
Eligibility Criteria:
Inclusion Criteria:
* Patient with cirrhosis and portal hypertension older than 18 old
* Patient who underwent a CT scan or MRI in the last 3 months
* The Mini-Mental State (MMS) test \>25.
* Patient capable of receiving and understanding information relating to the study and of giving his written informed consent.
* Patient affiliated to the French social security system
Exclusion Criteria:
* Cirrhotic patient with overt HE or history of persistent or recurrent HE.
* Hepatocellular carcinoma beyond Milan criteria.
* Portal vein thrombosis.
* Previous transjugular intrahepatic portosystemic shunt (TIPS) or surgical shunt.
* Presence of neurological or psychiatric disorder.
* Patient with treatment by benzodiazepines or opioid substitution.
* Pregnant or nursing women
* Patient in exclusion period of a previous study
* Patient under guardianship, trusteeship or the protection of justice or incapable of giving their own informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04807803
Study Brief:
Protocol Section:
NCT04807803